Episodios

  • HLTH 2025: Obesity Care Superstar Interviews
    Oct 22 2025

    VIEW EXCLUSIVE OTP SAVINGS!
    http://otplinks.com/


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Más Menos
    50 m
  • TRUMP: Ozempic Will Soon be $150 in the US! Meet the Reporter Who Made Him Say It!
    Oct 17 2025

    GET ACCESS TO OBESITY CARE AND MEDS AND SUPPORT OTP:
    https://lddy.no/1ndi6
    USE CODE: OTP25

    VISIT ALL OUR LINKS:
    https://linktr.ee/manonthemounjaro


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Más Menos
    30 m
  • Wegovy and Ozempic Users: FDA's Scathing Report on Major Novo Factory
    Oct 14 2025

    Visit our Sponsors and check out EXCLUSIVE OTP Savings!
    www.OTPLinks.com
    www.tryshed.com (use code OTP25 to save 25%)


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Más Menos
    28 m
  • Retatrutide News That Could Change Everything for GLP-1 Compounds
    Oct 7 2025

    SUPPORT OUR WORK:
    OTPLinks.com

    💉 Story 1 — Fractyl Health’s One-and-Done Gene Therapy for Obesity
    Fractyl Health just dropped preclinical results showing their GLP-1 + GIP gene therapy candidate RJVA-002 produced almost 30% weight loss in mice after a single dose. I sat down with Dr. Harith Rajagopalan, CEO of Fractyl Health, to talk about how this new Rejuva® platform works, what it means for people living with obesity and type 2 diabetes, and why gene therapy might be the future of metabolic care.

    🏛️ Story 2 — Medicare Coverage for GLP-1s? Dr. Oz Drops a Hint
    At the Aspen Institute, CMS Administrator Dr. Mehmet Oz said even a comment on GLP-1 coverage would be “market moving.” We break down what that means, why the Trump administration shelved a rule that would’ve added obesity meds to Medicare coverage, and how that decision might now be a bargaining chip to lower drug prices in exchange for tougher enforcement on compounding.

    ⚖️ Story 3 — The Retatrutide Ruling and the Future of Compounded Access
    A federal judge ruled the FDA acted “arbitrarily and capriciously” when it rejected Lilly’s bid to classify retatrutide as a biologic. That may sound technical, but if the FDA changes its stance, it could have huge implications for tirzepatide (Zepbound, Mounjaro) and semaglutide (Wegovy, Ozempic)—especially when it comes to compounding and patient access.


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Más Menos
    40 m
  • Sobriety Meets Weight Loss: The Ethan Suplee Interview
    Oct 7 2025

    View All My Links:
    https://www.OTPLinks.com

    Join Ethan's Live:
    2way.tv/ethansuplee


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Más Menos
    38 m
  • Mounjaro Hair Loss + NFL Lineman Discovers Power in Personalized Medicine
    Oct 3 2025

    otplinks.com
    stallybrand.com (code OTP10)


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Más Menos
    1 h y 11 m
  • Stopping Zepbound and Maintaining with Revita
    Sep 30 2025

    otplinks.com


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Más Menos
    42 m
  • GLP-1 Treatment and Advocacy with Dr. Leslie Golden
    Sep 26 2025

    https://linktr.ee/manonthemounjaro


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Más Menos
    1 h y 17 m